Might as well comment on $ALZN since this is my space and I've seen a decent amount of chatter. This company doesn't have a single drug outside of pre-clinical trials. It is a VERY far way off from doing anything. In the world of pharmacy, pre-clinical means very little. Also, this company is entering the hardest space for pharmaceuticals. These studies are traditionally very long since effects sometimes aren't seen until 4-6 weeks after use of the medication.

I maintain my conviction that $SPY is on its way to a bear market. I primarily use the 10Y-2Y treasury yield difference for my model TA, and as you can see it accurately predicted the two largest market declines in 2001 and 2008. $DXY has found support at the 50MA and its previous pivot point after making a series of higher highs and higher lows since the start of 2021. With all the talk of inflation, I do not believe people are positioned for a rapid increase in the value of USD.

Starting a thread on $ITRM because I see it getting pumped all over, and I think a lot of people are set up to get hurt. I am an emergency department pharmacist who treats UTI's, both complicated and uncomplicated, all day long. I'm also on my hospital's ID Stewardship Committee $ITRM's sole product is sulopenem/probenecid - a thiopenem antibiotic combined with an old gout medicine which is actually being used here to increase the half life of the antibiotic.